IBO · Impact BioMedical Inc
United States · RS rating 5 · As of 2026-10-14
| Price | 3.40 USD |
|---|---|
| 1-day change | -14.5% |
| RS rating (overall / 1M / 3M / 12M) | 5 / 2 / 7 / 12 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 19 / 2 / 31 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -61.1% |
| Distance from 52-week high | +65.5% |
| Market cap (USD) | $70.6M |